MetaADEDB 2.0 @ LMMD
Ablavar
(PIZALBORPSCYJU-QSQMUHTISA-I)
Structure
SMILES
[O-]C(=O)CN([C@H](CN(CC(=O)[O-])CCN(CC(=O)[O-])CC(=O)[O-])COP(=O)(OC1CCC(CC1)(c1ccccc1)c1ccccc1)[O-])CC(=O)[O-].[Na+].[Na+].[Na+].[Gd+3].[OH3+]
Molecular Formula:
C33H41GdN3Na3O15P+
Molecular Weight:
976.883
Log P:
-4.2701
Hydrogen Bond Acceptor:
17
Hydrogen Bond Donor:
1
TPSA:
288
CAS Number(s):
211570-55-7
Synonym(s)
1.
Ablavar
External Link(s)
PubChem Compound121488157
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Burning sensationFAERS: 9US FAERS
2NauseaFAERS: 8US FAERS
3PruritusFAERS: 4US FAERS
4Vulvovaginal burning sensationFAERS: 4US FAERS
5Genital burning sensationFAERS: 3US FAERS
6UrticariaFAERS: 3US FAERS
7Contrast media reactionFAERS: 2US FAERS
8Throat irritationFAERS: 2US FAERS
9Back PainFAERS: 1US FAERS
10Budd-Chiari SyndromeFAERS: 1US FAERS
11Chest PainFAERS: 1US FAERS
12DizzinessFAERS: 1US FAERS
13DysgeusiaFAERS: 1US FAERS
14Expired product administeredFAERS: 1US FAERS
15FlushingFAERS: 1US FAERS
16Genital erythemaFAERS: 1US FAERS
17HeadacheFAERS: 1US FAERS
18Injection site pruritusFAERS: 1US FAERS
19Post procedural complicationFAERS: 1US FAERS
20TachycardiaFAERS: 1US FAERS
21Uterine spasmFAERS: 1US FAERS
22VomitingFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.